Categories: News

Evolus to Report Second Quarter 2021 Results and Provide Business Update

NEWPORT BEACH, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its second quarter 2021 financial results and provide a business update on Wednesday, August 4, 2021, after the close of the U.S. financial markets.

Management will host a conference call and live webcast to discuss Evolus’ financial results at 4:30 p.m. ET that same day. A question-and-answer session will follow management’s remarks.

To participate in the conference call, dial (877) 407-6184 (U.S.) or (201) 389-0877 (international) or connect to the live webcast via the link on the Investor Relations page of the Evolus website at www.evolus.com.

Following the completion of the call, a telephonic replay can be accessed by dialing (877) 660-6853 (U.S.) or (201) 612-7415 (international). An archived webcast can also be accessed on the Investor Relations page of the Evolus website at www.evolus.com.

About Evolus, Inc.

Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Jeuveau® is powered by Evolus’ unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at www.evolus.com.

Jeuveau® is a registered trademark of Evolus, Inc.

Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.

Evolus, Inc. Contacts:

Investor Contact:
David K. Erickson, Evolus, Inc.
Vice President, Investor Relations
Tel: +1-949-966-1798
Email: IR@Evolus.com

Media Contact:
Crystal Muilenburg, Evolus, Inc.
Chief Marketing Officer
Tel: +1-949-284-4506
Email: media@evolus.com

Staff

Recent Posts

Corti Unlocks “Surgical” AI Improvement, Outperforming Big Tech in Interpretability Benchmark

New "GIM" method tops MIB global leaderboard, offering the industry a scalable way to inspect…

12 hours ago

New Year’s Fitness Resolutions: Why Recovery Is the Missing Piece

HOTWORX Shares Expert Guidance on Building Sustainable Fitness Goals That Go Beyond Just Working OutNEW…

12 hours ago

Zoom Room Dog Training Partners with Fi to Bring Dog Fitness Tracking Nationwide

Leading Dog Training Franchise Expands Human Level Fitness Tracking to Select LocationsLOS ANGELES, Dec. 18,…

12 hours ago

Top CEOs, Physicians and Innovators: HIMSS26 Announces Speakers and Exclusive Executive Experience Line-up

AdventHealth's David Banks, Savannah Bananas' Tyler Gillum, AMA's John Whyte, MD, MPH and Lenox Hill…

12 hours ago

WebPT Announces Advocate Physical Therapy and Tilton’s Therapy as Winners of the 2025 Ascend Awards

Practice of the Year and Innovator of the Year honorees recognized for patient-centered care, operational…

12 hours ago

Hootan Troy Farahmand: Leading With Purpose and Compassion in Modern Healthcare

As Chief Executive Officer of Alexso, Inc., a nationwide pharmaceutical distributor, Farahmand has earned recognition…

12 hours ago